Neurokinin‐1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial-Reference-Cited by-同舟云学术

Neurokinin‐1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial

Published:2021-01-07 Issue:5 Volume:35 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Welsh S.E.¹,Xiao C.¹,Kaden A.R.¹,Brzezynski J.L.¹,Mohrman M.A.¹,Wang J.¹,Smieszek S.P.¹^ORCID,Przychodzen B.¹,Ständer S.²,Polymeropoulos C.¹,Birznieks G.¹,Polymeropoulos M.H.¹

Affiliation:

1. Vanda Pharmaceuticals Inc. Washington DC USA

2. Department of Dermatology Center for Chronic Pruritus University Hospital Münster Münster Germany

Funder

Vanda Pharmaceuticals

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.17090

Reference11 articles.

1. Epidemiology of atopic dermatitis in adults: results from an international survey;Barbarot S;Allergy Eur J Allergy Clin Immunol,2018

2. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population

3. Atopic dermatitis: a review of diagnosis and treatment;Correale CE;Am Fam Physician,1999

4. Itch characteristics in atopic dermatitis: results of a web-based questionnaire

5. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting immunotherapeutic strategies for the management of atopic dermatitis;Exploration of Asthma & Allergy;2024-08-09

2. Advances in GPCR-targeted drug development in dermatology;Trends in Pharmacological Sciences;2024-08

3. Emerging Systemic Treatment Options in Atopic Dermatitis;Balkan Medical Journal;2024-07-05

4. The involvement of keratinocytes in pruritus of chronic inflammatory dermatosis;Experimental Dermatology;2024-07

5. Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials;Expert Opinion on Emerging Drugs;2024-04-28